. Remarkably, intestinal IgA achieves both immune protection and immune exclusion in a non-inflammatory manner, thereby promoting the establishment of a sustainable host-microbial mutualism 3 . The complex relationship between IgA and the intestinal microbiota is further exemplified by the fact that IgA responses are highly dependent on intestinal colonization by commensal microorganisms. Indeed, the number of IgAsecreting B cells is dramatically reduced in the intestine of germ-free animals and these cells are virtually absent in neonates before their exposure to bacteria 3 . In this Review, I summarize recent advances in our understanding of the function, regulation and geography of IgA class switching. In addition to analysing the signalling pathways underlying IgA class switching, I discuss new evidence indicating that commensal bacteria regulate intestinal IgA responses by promoting the crosstalk between B cells and multiple components of the mucosal innate immune system, including epithelial cells and dendritic cells (DCs).
Function of IgA class switching
Antibody diversification is essential for the immune system to mount protective humoral responses. B cells diversify their antibody repertoire through three main genetic alterations that occur in two distinct phases of B-cell development. In the antigen-independent phase, B-cell precursors lodged in the bone marrow generate antigen recognition diversity by assembling the exons that encode immunoglobulin heavy (H) and light (L) chain variable regions from individual variable (V), diversity (D) and joining (J) gene segments through V(D)J gene recombination 4 . This process is initiated by a lymphoid-cell-and sequence-specific RAG1 (recombination-activating gene 1)-RAG2 endonuclease complex and is completed by the non-homologous end-joining machinery 4 . Productive assembly of V H DJ H and V L J L exons allows the expression of IgH and IgL chains as cellsurface IgM by newly generated B cells 4 . After further differentiation and expression of IgD, B cells emerging from the bone marrow migrate to secondary lymphoid organs, where they initiate the antigen-dependent phase of B-cell development.
In the presence of antigen, mature B cells diversify their antibody repertoire through somatic hypermutation (SHM) and class switching 5, 6 . These processes take place in the germinal centres of secondary lymphoid follicles 7 and require the DNA-editing enzyme activationinduced cytidine deaminase (AID) 8 . The process of SHM introduces point mutations at high rates into V H DJ H and V L J L exons, thereby providing the structural correlate for selection by antigen of high-affinity immunoglobulin variants 5 . Class switching substitutes the IgH constant region µ (C µ ) and C δ genes encoding primary IgM and 
Biofilm
A population of aggregated microorganisms, typically concentrated at an interface (usually solid-liquid), that is held together by a protective self-produced extracellular polymeric substance matrix.
M cells (Microfold or membrane cells).
Specialized epithelial cells that deliver antigens by transepithelial vesicular transport from the gut lumen to intraepithelial dendritic cells and lymphocytes.
Peyer's patches
Large lymphoid follicles positioned in the antimesenteric wall of the small intestine and containing a large germinal centre. Each follicle is capped by a dome area and is flanked by a T-cell-rich perifollicular area.
IgD isotypes with C γ , C α or C ε genes through a process known as class-switch recombination (CSR) 9 . This molecular event generates secondary IgG, IgA and Ige isotypes that have the same antigen specificity as IgM and IgD, but different effector functions 10 . Indeed, secondary isotypes can activate multiple innate immune effector cells, including phagocytes, by binding to specific Fc receptors 10 . Together with post-IgA CSR modifications, IgA CSR generates multiple forms of membrane-bound IgA and of secreted IgA (sIgA), each characterized by a distinct location in the body and by distinct functions. Remarkably, some of these forms of IgA substantially differ in humans and mice (TABLE 1) . unlike mouse IgA, which comprises only one class, human IgA comprises two subclasses, IgA1 and IgA2, the latter being more abundant in the intestinal and genitourinary tracts. In addition, circulating IgA is predominantly monomeric in humans, but largely dimeric and oligomeric in mice.
Mucosal IgA. Mucosal secretions contain IgA dimers and oligomers in both mice and humans 1 . These IgA polymers originate from the interaction of IgA monomers with the J chain, a polypeptide synthesized by antibodysecreting cells 11 . In addition to assembling monomeric IgA, the J chain interacts with the polymeric immunoglobulin receptor (pIgR), an antibody-transporting protein expressed on the basolateral surface of mucosal epithelial cells 12 . The pIgR shuttles IgA across epithelial cells through a transcytotic process that culminates in the translocation of sIgA complexes to the mucosal surface 1 . These complexes comprise a secretory component that originates from the endocytic cleavage of pIgR and that confers mucophilic properties to sIgA 13, 14 . Remarkably, sIgA neutralizes toxins and pathogens without causing inflammation because of its inability to fix and activate the complement cascade 1 . In addition, sIgA anchors commensal bacteria to the mucus, thereby impeding their entry to the underlying intestinal mucosa 1 . Furthermore, sIgA promotes the establishment of a mutualistic host-microbe relationship by downmodulating the expression of pro-inflammatory epitopes by commensal bacteria 15 . Moreover, sIgA neutralizes microbial compounds with pro-inflammatory activity, such as lipopolysaccharide (LPS) 16 , and facilitates the formation of a biofilm that favours the growth of commensals while attenuating that of pathogens 17 . This property might depend on the ability of sIgA to agglutinate intestinal bacteria through carbohydrates associated with the Fcα region 1 . The secretory component would further increase the contributing capacity of sIgA to biofilm formation by anchoring intestinal bacteria to the mucus layer lining the epithelial-cell surface 14 . Finally, sIgA enhances mucosal immunity by delivering bacterial cargo to M cells (microfold or membrane cells) 18 19, 22 . Indeed, FcαRI engagement by IgA triggers the recruitment of SHP1 (SRC-homology-2-domaincontaining protein tyrosine phosphatase 1), a crucial negative regulator of multiple pro-inflammatory receptors 20 . Finally, it must be noted that, as mice do not express FcαRI, most of the data documenting the in vivo function of FcαRI were derived from mice expressing a human FCAR transgene (TABLE 1) .
Human IgA subclasses. The human IgA1 and IgA2 subclasses are encoded by two distinct C α 1 and C α 2 genes and possess a seemingly identical receptor-binding profile, but a different distribution in the body 1, 10 . Indeed, the circulating IgA pool is comprised mostly of IgA1, 
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Transferrin receptor
Also known as CD71, this receptor regulates the cellular import of iron by binding the iron-carrier protein transferrin. In addition, it mediates clearance of circulating IgA1 by renal mesangial cells.
Portal venous system
The venous system responsible for directing blood from parts of the gastrointestinal tract to the liver. [24] [25] [26] . Another difference between IgA1 and IgA2 relates to the fact that IgA1 has a longer hinge region than IgA2 (REF. 27 ). This feature renders IgA1 more susceptible to degradation by bacterial proteases that target the hinge region of IgA 23, 28 . Furthermore, compared to IgA1 antibodies, IgA2 antibodies seem to have superior Fcα-mediated, mannose-dependent agglutinating properties against enteric microorganisms and exhibit more V H -mediated reactivity against LPS, a key component of Gram-negative bacteria residing in the distal gut 23, 25 .
APOBEC
Mechanism of IgA class switching Mature B cells acquire IgA expression by undergoing CSR of C µ to C α (FIG. 1) . CSR involves an exchange of upstream donor C µ and C δ genes with a downstream acceptor C H gene through a recombinatorial process that is guided by switch (S) regions 10 . S regions are located upstream of each C H gene, except C δ , and consist of highly repetitive 1-12 kilobase sequences with G-rich non-template strands 9 . each S region is preceded by a short intronic (I) exon and a promoter that initiates germline C H gene transcription when the B cell is exposed to activating stimuli 9 . Germline transcription is crucial for CSR as it renders the S region a substrate for AID, an inducible APOBEC (apolipoprotein B mRNA-editing enzyme, catalytic component 1) family . Appropriate stimuli induce germline transcription of the constant heavy chain α (C α ) gene from the promoter (P α ) of the intronic α (I α ) exon through the switch α (S α ) region between I α and C α exons. In addition to yielding a sterile I α -C α mRNA, germline transcription renders the C α gene substrate for activation-induced cytidine deaminase (AID), an essential component of the CSR machinery. By generating and repairing DNA breaks at S µ and S α , the CSR machinery rearranges the IgH locus, thereby yielding a deletional recombination product known as the switch circle. This episomal DNA transcribes a chimeric I α -C µ mRNA under the influence of signals that activate P α . Post-switch transcription of the IgH locus generates mRNAs for both secreted IgA and membrane IgA. C α 1-3, exons that encode the C α chain of IgA; S, 3′ portion of C α 3 encoding the tailpiece of secreted IgA; M, exon encoding the transmembrane and cytoplasmic portions of membrane-bound IgA; αs, polyadenylation site for secreted IgA mRNA; αm, polyadenylation site for membrane-bound IgA mRNA. 
Isolated lymphoid follicles
Small lymphoid aggregates located in the antimesenteric wall of the small intestine and containing B cells, dendritic cells, stromal cells and some T cells. They may contain germinal centres. member encoded by AICDA 9 . AID is essential for CSR, as Aicda-knockout mice or patients with AICDA mutations develop hyper-IgM type 2 syndrome (HIGM2) and fail to generate class-switched antibodies, including IgA [29] [30] [31] . Germline C α gene transcription yields a primary I α -S α -C α transcript that is later spliced to form a noncoding germline I α -C α transcript 10 . The primary transcript physically associates with the template strand of the DNA to form a stable DNA-RNA hybrid 32 . This structure generates R loops in which the displaced nontemplate strand exists as a G-rich single-stranded DNA 33 . AID deaminates cytosine residues on both strands of the S-region DNA, thereby generating multiple DNA lesions that are ultimately processed into double-stranded DNA breaks 6, 9 . Fusion of double-stranded DNA breaks at S α and S µ through the non-homologous end-joining pathway induces looping-out deletion of the intervening DNA, thereby juxtaposing V H DJ H to C α (REFS 6,9). This process yields a chromosomal V H DJ H -C α sequence, which encodes the IgA protein, and an extrachromosomal switch circle, which encodes a chimeric I α -C µ switch circle transcript 34 .
Together with AID transcripts and switch circles, switch circle I α -C µ transcripts have a short half-life and therefore their detection indicates ongoing CSR 34, 35 .
T-cell-dependent IgA class switching Most antigens, including microbial proteins, initiate protective humoral responses in germinal centres, which are specialized follicular environments that foster B-cell proliferation, AID expression and antibody gene diversification through CSR and SHM 7, 8 . In general, germinal-centre reactions are highly dependent on cognate interactions between antigen-specific B cells and CD4 + T cells that express CD40 ligand (CD40L; also known as CD154), a tumour-necrosis factor (TNF) family member that engages CD40 on B cells 36 . Antigen exposed on the surface of follicular DCs selects germinal-centre B cells expressing a high-affinity B-cell receptor (BCR), selected B cells thereafter differentiate into long-lived memory B cells and antibody-secreting plasma cells 37 . In the gut, T-cell-dependent antibody responses are strongly biased towards IgA and involve activation of B cells by antigen in the organized lymphoid tissue of Peyer's patches, mesenteric lymph nodes and isolated lymphoid follicles 1, 2 . In addition to inducing AID, B-cell-activating signals induce germline C H gene transcription 9 . This process confers specificity to CSR 38 , because the promoter upstream of each C H gene responds only to a specific set of signal-induced transcription factors 10 . Promoters upstream of C α genes, or I α promoters, become activated in response to transforming growth factor-β1 (TGFβ1) [39] [40] [41] , a cytokine that is secreted by many cell types, including various subsets of CD4 + T cells 42, 43 . Together with CD40L, TGFβ1 is essential for the induction of T-cell-dependent IgA class switching 10 .
Role of TGFβ1 in germline C α gene transcription. TGFβ1 is a pleiotropic cytokine that belongs to the TGFβ superfamily 42 . TGFβ1 is derived from the proteolytic cleavage of a pro-region, known as LAP (latency associated peptide), which undergoes dimerization and thereby forms an active molecule of 25 kDa 42 . Active TGFβ1 engages a heterotetrameric TGFβ receptor (TGFβR) complex composed of two type I and two type II transmembrane proteins that have serine/threonine kinase activity 42 . Signals emanating from the TGFβR induce both activating and inhibitory effects in a broad range of target cells. In B cells, low concentrations of TGFβ1 initiate C α gene transcription (FIG. 2) , whereas high concentrations suppress B-cell proliferation and differentiation, including antibody secretion 44 . This dual role is important for the homeostasis of the immune system. Indeed, mice with defective TGFβ1 signalling develop inflammatory and autoimmune disorders 42 . TGFβR signals through mothers against decapentaplegic homologue 2 (SMAD2), SMAD3 and SMAD4 proteins, which form homo-and hetero-oligomeric complexes that bind to SMAD-binding elements (SBes) on the promoters of target genes 42, [45] [46] [47] . This signalling pathway is negatively regulated by SMAD7 (REF. 42 ). The activation of I α promoters requires the cooperation of SMAD proteins with runt-related transcription factor 3 (RuNX3; also known as CBFα3) 45, 47, 48 , a TGFβ1-inducible member of the RuNX family of proteins with a DNA-binding runt domain 49 . SMAD proteins and RuNX3 bind to a direct repeat unit on I α promoters that is known as the TGFβ1 responsive element (TGFβRe) 50 . This conserved cisregulatory DNA region contains two tandemly arrayed RuNX-binding elements (RBes) that are adjacent to SBes 45, 47, 48 . The proximity of SBes and RBes provides a structural correlate for the physical interaction of SMAD proteins with RuNX3, which in turn is central to the activation of I α promoters by TGFβ1 (REFS 45, 47, 48) . This cytokine is important not only for the initiation of C α gene transcription in vitro, but also for the induction of IgA class switching in vivo. Indeed, B-cell-conditional TGFβRII-deficient mice, SMAD2-deficient and SMAD3-deficient mice produce less IgA under steady-state and immunizing conditions in both systemic and mucosal sites, including the Peyer's patches [51] [52] [53] . Conversely, B cells from mice lacking SMAD7 show increased IgA CSR in response to TGFβ1 (REF. 54 ).
In addition to SBes and RBes, both mouse and human I α promoters contain a cyclic AMP response element (CRe) associated with the TGFβRe 50 . This CRe site binds CRe binding protein (CReB), a TGFβ1-inducible factor that cooperates with SMAD and RuNX3 proteins 46 . Downstream of the CRe site, the mouse I α promoter contains an ets site, which binds eLF1 (ets-like factor 1) and Pu.1 (REF. 55 ). These ets family members cooperate with SMAD and CReB proteins to activate I α (REF. 55 ). Finally, near its main transcription initiation site, the mouse I α promoter has a second CRe site and a site for PAX5 (paired box protein 5; also known as BSAP), which represses C α gene transcription under basal conditions 56 .
Role of CD40L in CSR to C α . CD40L is an essential requirement for T-cell-dependent class switching, including IgA class switching (FIG. 2) , and CD40L cooperates with TGFβ1 to induce IgA CSR in vitro [57] [58] [59] [60] [61] . 62, 63 . A significant systemic IgA deficiency can also be observed in humans affected with CD40L or CD40 signalling defects due to HIGM1 and HIGM3 syndromes, respectively 64, 65 .
CD40L expressed on the surface of antigen-activated CD4 + T cells activates B cells by engaging the CD40 receptor 36 . By recruiting TNF-receptor-associated factor (TRAF) adaptor proteins 36 , CD40 forms a signalling platform that activates the IκB kinase (IKK) enzymatic complex 66 . This IKK complex mediates phosphorylation + T cells release the active transforming growth factor-β1 (TGFβ1) after processing of a latency-associated peptide (LAP). TGFβ1 forms a heteromeric TGFβ receptor (TGFβR) complex on B cells comprising TGFβRII and TGFβRI subunits. TGFβR undergoes degradation on binding by I-SMAD (inhibitory SMAD (mothers against decapentaplegic homologue)) proteins, such as SMAD7, which recruits ubiquitin ligases of the SMURF (SMAD ubiquitylation regulatory factor) family to TGFβRI. Alternatively, the TGFβR remains on the B-cell surface to activate SMAD proteins. In the presence of TGFβ1, TGFβRII kinases phosphorylate TGFβRI, leading to the activation of TGFβRI kinases. These kinases induce the phosphorylation of receptor-regulated SMAD (R-SMAD) proteins, including SMAD2 and SMAD3, thereby releasing them from the plasma membrane-anchoring protein SARA (SMAD anchor for receptor activation). After forming homo-oligomeric complexes, as well as heterooligomeric complexes with SMAD4 -a co-mediator SMAD (Co-SMAD) protein -R-SMAD proteins translocate to the nucleus, where they bind to SMAD-binding elements (SBEs) on target gene promoters, including constant heavy chain α (C α ) gene promoters. These SMAD complexes further associate with constitutive and TGFβR-induced co-factors, including runt-related transcription factor 3 (RUNX3), which binds to RUNX-binding elements (RBEs), cyclic AMP response element binding protein (CREB), which binds to a cyclic AMP response element (CRE), and Ets-like factor 1 (ELF1), which binds to an Ets-binding site. In addition to TGFβ, CD4 + T cells express CD40 ligand (CD40L), which elicits oligomerization of CD40 on B cells, recruitment of tumour-necrosis-factor-receptor-associated factors (TRAFs) to CD40, activation of the IκB kinase (IKK) complex, phosphorylation of IκB (inhibitor of nuclear factor-κB (NF-κB)), and IκB degradation. IκB-free NF-κB translocates to the nucleus to induce the activation-induced cytidine deaminase (AICDA) gene promoter. Although NF-κB binds to an NF-κB-binding (κB) site on the C α promoter, it has a marginal role in the transcription of the C α gene. of inhibitor of NF-κB (IκB) proteins, which retain nuclear factor-κB (NF-κB) in a cytoplasmic inactive form 66 . Phosphorylation of IκBα by the IKK complex is followed by ubiquitylation and proteasome-dependent degradation of IκBα, which allows NF-κB to translocate into the nucleus 66 . Here, NF-κB binds to cis-regulatory κB sites, thereby determining the activation of promoters located upstream of key B-cell genes, including I γ and I ε (REF. 10 ).
In addition to triggering IgG and Ige class switching 10 , NF-κB has an important role in IgA class switching, as this process is impaired in B cells from NF-κB-deficient mice 67 . Yet, I α promoters contain only one κB site located downstream of the ets site 55 . This κB site neither induces nor enhances the activation of I α promoters 55 , suggesting that NF-κB regulates IgA CSR at a level other than germline C α gene transcription. Most likely, NF-κB mediates the induction of AID expression 68 , an essential requirement for IgA CSR, in addition to germline C α gene transcription 9 .
Remarkably, CD40L can induce IgA class switching in combination with cytokines other than TGFβ1, including interleukin-2 (IL-2), IL-4, IL-5, IL-6, IL-10 and VIP (vasoactive intestinal peptide) 58, 60, 61, 67, 69, 70 . These cytokines may enhance the production of endogenous TGFβ1 by B cells exposed to CD40L, thereby triggering IgA CSR through an autocrine TGFβ1-dependent loop 61 . In addition, they may augment the proliferation and plasma-cell differentiation of the B cells that have switched to IgA in response to CD40L and autocrine TGFβ1 (REF. 10 ).
T-cell-independent IgA class switching T-cell-dependent antibody responses take at least 5 to 7 days to develop, which is too much of a delay to neutralize pathogens that replicate quickly, commensal bacteria and dietary antigens. To compensate for this limitation, specialized B-cell subsets can rapidly produce IgM as well as class-switched IgG and IgA in a CD4 + T-celland CD40L-independent manner 71 . In mice, intestinal T-cell-independent IgA responses rely on a peritoneal B-1-cell subset, which has ontogenic, phenotypic and genotypic features that are distinct from conventional (or B-2) B cells [72] [73] [74] . Indeed, B-1 cells express unmutated IgA antibodies (that is, they have not been subjected to SHM) that recognize multiple specificities with low affinity 1, 2 . These antibodies mediate immune exclusion of commensals and provide limited protection against some pathogens, including rotaviruses and Salmonella typhimurium [75] [76] [77] . Systemic T-cell-independent IgA responses also exist and these appear to require B cells in the marginal zone of the spleen 1, 78 . Similar to B-1 cells, mouse marginal-zone B cells express polyreactive IgA (and IgM) antibodies that may provide a second line of defence against commensal bacteria that breach the epithelial-cell barrier 1, 71 . T-cell-independent IgA responses are also present in humans, as patients with severe CD4 + T-cell deficiency due to HIV infection, as well as patients lacking CD40 retain intestinal IgA class switching 26 . Although humans seem to lack B-1 cells, they have additional B-cell subsets that might be involved in T-cell-independent IgA responses, including IgM + memory B cells 79 . These B cells can be detected in the circulation and in the marginal zone of the spleen, express mutated V(D)J genes, and undergo CD40-independent IgM and IgG production in response to bacterial polysaccharides, a canonical T-cell-independent antigen 79, 80 . An additional human B-cell subset that is possibly involved in T-cellindependent IgA responses is the transitional B-cell subset, which expresses polyreactive antibodies encoded by unmutated V(D)J genes [81] [82] [83] . T-cell-independent antigens initiate IgA class switching by linking B cells with multiple innate immune pathways. whereas some T-cell-independent antigens, such as LPS, activate B cells through Toll-like receptors (TLRs) 84 , others, such as polysaccharides, activate B cells through their BCR 85 . T-cell-independent antigens can also provide additional B-cell-stimulating signals through DCs. Positioned as sentinels throughout the body, DCs sample T-cell-independent antigens from the environment and thereafter convey them to a nondegradative endocytic pathway 86 . Subsequent recycling of the endocytosed antigen to the plasma membrane is followed by its presentation to B cells [86] [87] [88] [89] [90] . During this process, DCs release soluble class-switch-inducing factors related to CD40L, including B-cell activating factor (BAFF; also known as BLyS) and a proliferation-inducing ligand (APRIL) [91] [92] [93] (see later).
Role of microbial TLR ligands in CSR to C α . The TLR4 ligand LPS, along with TGFβ1, can also initiate germline C α gene transcription and CSR from C µ to C α in mouse B cells 84, 94 (FIG. 3) ; however, the mechanism by which TLRs trigger IgA CSR in B cells remains unclear. TLRs activate NF-κB by recruiting various adaptor proteins, including myeloid differentiation primary-response protein 88 (MyD88), to their cytoplasmic tail 95 . MyD88 forms a signalling complex with multiple downstream elements, including IL-1-receptor-associated kinases (IRAKs) and TRAF6, thereby causing IKK activation and subsequent nuclear translocation of NF-κB 96 . Surprisingly, NF-κB is not required for the activation of I α promoters, which is highly dependent on other transcription factors [45] [46] [47] [48] 55, 97 . Instead, NF-κB may be required by TLRs to induce the expression of AID 26, 34, 98, 99 . Although sufficient to initiate IgA CSR 41 , TGFβ1 and LPS require additional signals, such as BCR engagement by dextran-conjugated IgD-specific antibodies, to induce significant IgA expression and secretion 58, 78 . These additional signals may be needed to optimize the expansion and differentiation of the B cells that have undergone IgA CSR in response to TGFβ1 and LPS. However, they may also be necessary to introduce crucial epigenetic changes rendering the S α region more accessible to the CSR machinery. Indeed, mouse B cells undergo increased histone 3 acetylation at the S α region on exposure to a range of stimuli including TGFβ1, LPS and a BCR ligand 100 . In addition, IgA CSR and production are enhanced by histone H3 methyltransferase Suv39h1 both in vitro and in vivo 101 . Suv39h1 might sequester an S α -specific repressor by inducing relocation of proteins associated with heterochromatin, such as the polycomb group proteins HPC2 and HP1β (REF. 101 ). Alternatively, 
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Suv39h1 might induce transcriptional inhibition of an S α -specific repressor. A candidate for such a repressor is LSF (late SV40/CP2 factor), a protein that binds S α (and S µ ) segments and inhibits IgA CSR 102 . Interestingly, B-1 and marginal-zone B cells undergo IgA class switching more effectively than B-2 cells in response to T-cell-independent stimuli. This circumstance possibly reflects the unique antigen recognition profile of B-1 and marginal-zone B cells, which express both germline gene-encoded (that is, TLRs) and somatically recombined (that is, BCRs) antigen receptors 103 . when exposed to BAFF, LPS and TGFβ1, B-1 and marginal-zone B cells switch to IgA expression more readily than B-2 cells 78 . Such distinctive responsiveness may reflect the stimuli available in the microenvironments in which these B-cell subsets usually operate. Similar to B-1 and marginalzone B cells, human IgM memory and transitional B cells exhibit robust antibody responses to microbial TLR and BCR ligands 83, 104 . Yet, the contribution of these human B-cell subsets to T-cell-independent IgA class switching is presently not known.
Role of BAFF and APRIL in CSR to C α . In addition to engaging TLRs on B cells, microbial products stimulate the release of BAFF and APRIL by DCs (FIG. 3) . These two molecules are soluble B-cell-stimulating factors that are structurally and functionally related to CD40L 26, 91, 99 . In the presence of other cytokines, BAFF and APRIL induce Figure 2) . DCs also present bacterial products to B cells, thereby activating Toll-like receptors (TLRs). By recruiting myeloid differentiation primary-response protein 88 (MyD88), interleukin-1-receptor-associated kinase 1 (IRAK1) and IRAK4, TLRs induce activation of the IκB (inhibitor of nuclear factor-κB (NF-κB)) kinase (IKK) complex, phosphorylation and degradation of IκB. IκB-free NF-κB translocates to the nucleus to induce the promoter of the activation-induced cytidine deaminase (AICDA) gene. DCs further activate B cells by engaging transmembrane activator and calcium-modulating cyclophilin-ligand interactor (TACI) through B-cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL). TACI activates NF-κB after recruiting tumour-necrosis-factorreceptor-associated factors (TRAFs) to its cytoplasmic domain, thereby triggering AICDA gene expression. It is unknown whether TLRs and TACI also activate the C α promoter. Co-SMAD, co-mediator SMAD; CRE, cyclic AMP response element; CREB, CRE-binding protein; ELF1, Ets-like factor 1; κB, NF-κB-binding site; RUNX3, runt-related transcription factor 3; RBE, RUNX-binding element; SARA, SMAD anchor for receptor activation; SBE, SMAD-binding element; SMAD, mothers against decapentaplegic homologue; TGFβR, TGFβ1 receptor.
germline C α gene expression, AID expression and IgA class switching in a CD40-independent manner 26, 91, 99, 105 . This effect depends on expression of the transmembrane activator and calcium-modulating cyclophilin-ligand interactor (TACI) receptor by B cells, as B cells lacking TACI do not express AID or undergo CSR in response to BAFF or APRIL 105 . In agreement with these data, TACI-deficient mice exhibit decreased steady-state serum IgA levels and make less IgA in response to T-cellindependent (but not T-cell-dependent) antigens 106 . The key role of TACI in T-cell-independent IgA responses is further indicated by its elevated expression by B-1 cells 107 . Similar to mice, humans develop selective IgA deficiency when TNFRSF13b 108 , the gene encoding TACI, is mutated
. TNFRSF13b mutations also cause common variable immunodeficiency, which is associated with pan-hypogammaglobulinaemia 108, 109 . This more pervasive phenotype may reflect the ability of TACI to enhance CD40-dependent antibody secretion in addition to promoting CD40-independent class switching 110, 111 . BAFF and APRIL also bind to BAFF receptor (BAFFR; also known as BR3), B-cell maturation antigen (BCMA) and heparan-sulphate proteoglycans (HSPGs) 92, 93 . engagement of BAFFR by BAFF delivers survival signals and, to some extent, CSR-inducing signals to peripheral B cells 105, 112 . By contrast, engagement of BCMA by BAFF or APRIL delivers survival signals to plasma cells 113 , but has no effect on CSR. Similarly, engagement of HSPGs by APRIL conveys survival and differentiation, but not CSR signals to plasma cells 110 . of note, HSPGs form highly efficient TACI and BCMA signalling platforms by generating APRIL oligomers through the binding of their glycosaminoglycan side chains to a basic QKQKKQ aminoacid sequence that is proximal to the amino terminus of APRIL 93 . The mechanism by which TACI triggers IgA CSR remains unclear. Similar to CD40, TACI is thought to induce TRAF-dependent activation of the IKK complex, followed by nuclear translocation of NF-κB 114 . This pathway may be crucial to induce AID expression 68 , but is unlikely to have a key role in germline C α gene transcription, which usually requires signals from TGFβ1 (REF. 55 ). Yet, this cytokine is not absolutely required by BAFF and APRIL to induce IgA CSR, at least in murine B cells 105 , raising the possibility that TACI activates I α promoters in a TGFβR-independent manner. Although BAFF and APRIL are sufficient to induce IgA secretion in mouse B cells 105 , human B cells require additional stimuli, including BCR or TLR engagement and IL-10 (REFS 26,91,99), which enhances IgA class switching and production by functioning in synergy with paracrine or autocrine TGFβ1 (REFS 57, 61, 115) . In summary, the experimental evidence presently available clearly points to the existence of an important innate pathway to IgA class switching that is highly dependent on the engagement of TACI on B cells by BAFF and APRIL. Yet, more studies are needed to elucidate the co-stimuli and signalling events required by TACI to initiate IgA CSR and production.
Geography of IgA class switching
By ensuring the establishment of complex commensal and symbiotic relationships, co-evolution of mammals and bacteria over the past 200 million years has contributed to the development of multiple follicular and extrafollicular layers of protection in the intestinal mucosa (FIG. 4) . These layers encompass both T-celldependent and T-cell-independent pathways for IgA class switching and production.
T-cell-dependent IgA CSR in Peyer's patches. Prior studies have confirmed that the intestinal IgA inductive sites are the Peyer's patches, isolated lymphoid follicles and mesenteric lymph nodes 1, 2, 116 . The key role of these organized lymphoid structures in the induction of intestinal IgA was demonstrated in mice that have abnormal follicles as a result of a genetic manipulation or experimental disruption of the signalling pathways required for lymphoid organogenesis 1, 2, 117 . In general, Peyer's patches are thought to generate high-affinity IgA antibodies to toxins and pathogens through a canonical T-cell-dependent pathway that is orchestrated by DCs. Positioned in the subepithelial dome of Peyer's patches (FIG. 5) , DCs capture antigen from the intestinal lumen either directly by extending transepithelial projections or indirectly via M cells 19 . After migrating into the perifollicular area of the Peyer's patches, DCs present the captured antigen to CD4 + T cells, thereby inducing effector T cells that release IgA-inducing cytokines, including TGFβ1, IL-4, IL-6 and IL-10 (REFS 117-119). This response is enhanced by thymic
Box 1 | Lessons learned from IgA deficiencies
Selective IgA deficiency and common variable immunodeficiency (CVID) are the most common forms of primary immunodeficiency 137 . Selective IgA deficiency causes an isolated IgA defect, whereas CVID impairs IgM, IgG and IgA responses 108, 109, 137 . Although often asymptomatic, individuals with selective IgA deficiency and CVID can suffer from respiratory and gastrointestinal infections, respond poorly to T-cellindependent immunogens and develop B-cell lymphoproliferative disorders and autoimmunity 137 . In addition, some individuals with CVID develop chronic intestinal disorders, including inflammatory bowel disease, coeliac disease and nodular lymphoid hyperplasia (NLH), a follicular B-cell hyperplasia of the proximal intestine 2, 137 . These nodules are similar to isolated lymphoid follicles and can trigger bleeding and intussusception, a telescoping prolapse of the intestine into an immediate adjacent segment. Hyperstimulation of isolated lymphoid follicles by an altered microflora may have a role in NLH, as mice lacking activation-induced cytidine deaminase (AID), an enzyme essential for IgA class switching 8 , develop NLH-like lesions, as well as systemic and mucosal B-cell hyperactivation due to an abnormal expansion of commensal anaerobic bacteria in proximal intestinal segments 31, 126 . B-cell hyperactivation is also present in mice lacking transmembrane activator and calcium-modulating cyclophilinligand interactor (TACI), a class-switch-inducing receptor involved in T-cellindependent IgA responses 105, 106 . Similar to individuals with selective IgA deficiency or CVID, TACI-deficient mice develop autoimmune and lymphoproliferative disorders and produce less IgM, IgA and IgG in response to T-cell-independent antigens 106 . Remarkably, TACI is defective in a subset of individuals with selective IgA deficiency and CVID 108, 109 . Overall, the clinical manifestations of IgA deficiencies reflect recent evidence indicating that IgA class switching is important not only to protect against pathogens 77, 117 , but also to preserve a mutualistic host-microorganism relationship via modulation of the gene-expression profile of commensal bacteria 15 . By preserving the homeostasis of the gut microflora, IgA may prevent the overstimulation of mucosal and systemic B cells and the subsequent expansion of autoreactive and neoplastic clones. Nature Reviews | Immunology 
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Bacteria FAE stromal lymphopoietin (TSLP), a DC-conditioning IL-7-like cytokine derived from epithelial cells that promotes the formation of non-inflammatory T cells with IgA-inducing functions 119, 120 . ultimately, these non-inflammatory effector T cells trigger CSR from C µ to C α through a CD40-dependent pathway involving cognate T-cell-B-cell interactions in the germinal centre of mucosa-associated lymphoid follicles 2 .
In addition to triggering the inductive phase of a T-cell-dependent IgA response, mucosal DCs initiate the effector phase of the mucosal humoral response by releasing retinoic acid, a compound derived from vitamin A that upregulates the expression of gut-homing receptors, including α 4 β 7 -integrin and CC-chemokine receptor 9 (CCR9), by IgA class-switched B cells 121 . This upregulation enables IgA + B cells to migrate from Peyer's patches to the gut lamina propria via the draining mesenteric lymph nodes, the thoracic duct and blood 121 . During this migration, IgA + B cells develop into IgA-secreting plasma cells under the influence of cytokines released by lymphoid, stromal and epithelial cells and by DCs. The reason why class switching is biased towards IgA in the Peyer's patches remains unclear, although the release of IL-6, IL-10, TGFβ1, retinoic acid and nitric oxide by gut DCs seems to have an important role 119, [121] [122] [123] . Peyer's patches can also induce IgA class switching through an alternative T-cell-dependent pathway that does not require BCR signals from canonical cognate T-cell-B-cell interactions, but that rather relies on TLR signals from commensal bacteria 124 . This observation would explain why a fraction of B-2 cells from Peyer's patches expresses a restricted IgA repertoire that does not show the sequential acquisition of somatic hypermutations that would be expected in a canonical germinal-centre reaction 125 . By using both canonical and alternative T-cell-dependent pathways, Peyer's patches may generate IgA antibodies to control both commensal and pathogenic bacteria 1, 117, 126 .
T-cell-independent IgA CSR in the lamina propria. In mice, T-cell-independent IgA production requires B-1 cells and preferentially targets commensal bacteria 3 . Indeed, experiments in which radiation chimaeras have been generated with allotypic markers to distinguish the IgA derived from B-1 and B-2 cells indicate that up to 50% of the intestinal IgA originates from B-1 cells 73, 127 , although this point remains controversial 128 . Most of this IgA is produced in a T-cell-independent manner, because MHC-class-II-deficient mice (lacking cognate T-cell-B-cell interactions) or mice deficient for the T-cell receptor β-and γ-chains (lacking T cells) retain B-1-cell-mediated IgA responses to commensal bacteria 74, 76 . Recent data indicate that also the human intestine supports T-cell-independent IgA production 26 . But where do B cells undergo T-cell-independent IgA class switching? one probable place is the intestinal lamina propria, as IgA + B cells from this site contain hallmarks of ongoing IgA CSR, including AICDA gene transcripts, AID protein and I α -C µ switch circle transcripts 2, 26, 129 . In humans, these indicators are still present in the absence of CD4 + T cells, CD40 signalling and/or germinal centres 26 , suggesting that lamina-propria B cells can undergo IgA CSR in situ in a T-cell-independent manner. Consistent with this possibility, lamina-propria B cells retain IgA CSR in an AID mouse reporter strain that lacks germinal centres as a result of a deletion of the gene for the transcription factor oCA-B (oct co-activator from B cells; also known as oBF1) 129 . Although still debated 130 , the presence of IgA CSR in the lamina propria is in agreement with compelling evidence showing that CSR is not restricted to lymphoid follicles, but also occurs in extrafollicular lymphoid areas 131 , including subepithelial areas 99 . In both mice and humans, lamina-propriaderived IgA CSR-inducing signals may target multiple IgM + B-cell subsets that originate from various sites, including the peritoneum, mucosal follicles and bone marrow 26, 31, 73, 129, 132 . A full characterization of these IgM + B-cell subsets is made more difficult by the fact that they may rapidly modify their phenotype on entering the microenvironment of the lamina propria.
Role of DCs in CSR to C α . How do lamina-propria B cells undergo T-cell-independent IgA CSR in response to T-cell-independent antigens? In humans, DCs acquire B-cell-licensing functions, including IgA-inducing activity, following stimulation by microbial TLR ligands (FIG. 5) , such as LPS 91, 115 . In mice, intestinal DCs initiate T-cell-independent IgA responses by activating B-1 cells after loading commensal bacteria 74, 76 . Consistent with these findings, DCs in the intestinal lamina propria continuously sample antigens from the intestinal lumen through transepithelial projections 133, 134 . This sampling activity probably results in the induction of IgA CSRinducing factors, such as BAFF and APRIL 26, 91, 99 , and in the presentation of T-cell-independent antigens to B cells [86] [87] [88] [89] [90] . of note, bacterial TLR ligands have recently been shown to generate a mucosal DC subset that expresses TNF and inducible nitric oxide synthase (iNoS) and has potent IgA-inducing functions 123 . Nitric oxide can enhance T-cell-independent IgA class switching by stimulating BAFF and APRIL production by lamina-propria DCs and enhance T-cell-dependent IgA class switching by upregulating TGFβR expression by B cells from the Peyer's patches 123 . In this way, TNF + iNoS + DCs would contribute to the striking IgA bias observed in the gut.
Role of epithelial cells in CSR to C α . DCs are unlikely to be the only inducers of T-cell-independent antibody responses in the gut 135 . Positioned at the interface between the antigen-rich intestinal lumen and the B-cellrich lamina propria, epithelial cells produce numerous mediators with IgA-inducing function, including IL-10 and TGFβ1. Similar to respiratory epithelial cells 99, 136 , human colonocytes also express BAFF and APRIL (FIG. 5) and further upregulate this expression on sensing bacteria via TLRs through a mechanism that involves DC activation by TSLP 26, 99 . Together with IL-10, APRIL triggers IgA2 CSR in B cells 26 , suggesting that epithelial cells are central to the induction of IgA2 at mucosal sites colonized by a large microbiota, such as the colon 24, 25 . At these sites, IgA2 may be more beneficial than IgA1, perhaps because IgA2 is more resistant than IgA1 to enzymatic digestion by bacterial proteases 25, 28 . The presence of local IgA2 CSR in the human colonic lamina propria is consistent with several observations. First, the colonic lamina propria contains higher levels of IgA2 than IgA1, whereas colonic lymphoid follicles contain more IgA1 than IgA2 (REF. 26 ), suggesting that both inductive and migratory events contribute to IgA2 production in the colonic lamina propria. Second, the colonic lamina propria retains IgA2, as well as hallmarks of ongoing CSR, in the absence of functional CD4 + T cells, CD40 signals and germinal centres 26 , which indicates that IgA2 responses proceed locally in a T-cell-independent manner. Third, the colonic lamina propria contains traces of both direct IgM-to-IgA2 and sequential IgA1-to-IgA2 CSR events, which are both highly dependent on APRIL 26 . Although direct IgA2 CSR can take place in unmutated or mutated lamina-propria IgM + B cells originating from systemic and mucosal sites, sequential IgA2 CSR would occur in mutated laminapropria IgA1 + B cells arriving from mucosal follicles. In this way, epithelial cells would maximize the diversity of the IgA2 repertoire released onto the mucosal surface. Finally, APRIL may enable epithelial cells to optimize mucosal IgA2 secretion by enhancing plasma-cell survival and differentiation 110, 113 . Altogether, the available evidence indicates that human intestinal epithelial cells use APRIL to trigger T-cell-independent production of protease-resistant IgA2 antibodies, which may be more suited than IgA1 antibodies to cope with the dense microbial community of the large intestine. Consistent with its ability to induce IgA1 in addition to IgA2 class switching 26 , APRIL is also expressed by epithelial cells at mucosal sites with predominant IgA1 production, such as the respiratory tract 23, 26, 136 . This implies that APRIL influences the IgA1-IgA2 balance in the context of other unknown factors that are probably specific to each mucosal site.
Concluding remarks
Despite recent advances, the functions and mechanisms of mucosal IgA class switching remain unclear. Commensal communities are strikingly different at distinct mucosal sites and may influence the subclass and binding properties of IgA class-switched antibodies in a site-specific manner. However, little is known about the role of individual bacterial species in the induction of IgA class switching and about the mechanisms by which class-switched IgA antibodies modify the composition and mutualistic relationship between the commensal microbiota and the host. we also need more information on the phenotype, IgA class-switch-inductive properties, and activation requirements of individual DC and B-cell subsets at distinct mucosal sites. Furthermore, more data are needed on the follicular and extrafollicular pathways that mediate mucosal IgA class switching and on the role of these pathways in the preservation of mucosal homeostasis and in the generation of immune protection against mucosal pathogens
. Addressing these questions will not only help to develop more efficient mucosal vaccines, but also to prevent and treat mucosal inflammatory disorders.
Box 2 | Mucosal vaccines
Mucosal immune responses provide a first line of defence against infectious agents that use mucosal surfaces as a portal site of entry. Growing evidence indicates that the generation of mucosal immunity requires topical immunization 19, 138 . Indeed, intramuscular or subcutaneous vaccines induce poor mucosal immune protection compared to oral, nasal, vaginal or rectal vaccines. Unfortunately, only a few mucosal vaccines are currently available and these include oral vaccines against poliovirus, Salmonella typhimurium, Vibrio cholerae and rotavirus, as well as an inhalable vaccine against influenza virus 19, 138 . The development of mucosal vaccines has lagged behind that of other vaccines owing to a limited knowledge of mucosal immunity and to the technical challenges associated with the measurement of correlates of mucosal protection, including IgA antibodies in mucosal secretions. Additional challenges relate to the fact that mucosal vaccines are diluted by mucosal secretions, captured by mucus gels, attacked by enzymes and excluded by epithelial-cell barriers. Furthermore, in the absence of adequate adjuvants, mucosal antigens tend to induce tolerance rather than immunity 19, 138 . Hence, an effective mucosal vaccine against infectious agents should avoid physical elimination and enzymatic digestion, target mucosal inductive sites and stimulate the innate immune system to generate effective adaptive immune responses 19, 138 . Stimulated by the threat posed by HIV, current research efforts aim at identifying new mucosal delivery systems and adjuvants. Whether mucosally transmitted or injected, HIV preferentially replicates in mucosal districts, where it establishes viral reservoirs. Therefore, consensus is growing for the notion that effective HIV vaccines should elicit both cellular and humoral immune responses in mucosal regions 19, 138 . Secreted IgA, with or without broad neutralizing activity, may prevent HIV from contacting mucosal surfaces, adhering to epithelial cells or crossing the epithelial-cell barrier 139 . Indeed, there is some evidence from highly exposed, uninfected individuals that IgA in mucosal secretions increases resistance to sexually transmitted HIV infection 140 .
